logo
15:59 Dec 05

Alivus Life Sciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
883.75
+11.70 (+1.34%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alivus Life Sciences Ltd. Financials

Alivus Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
883.75
+11.70 (+1.34%)
15:59 Dec 05
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

42/100
Mid Valuation

Technical

33/100
Technically Bearish

Strength

7

Weakness

10

Opportunity

1

Threats

1

17.23 %

ROE %

14.23 %

ROA %

43.23

EPS

229.92

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
2123.21 2161.22 2283.21 2386.88 2400.11
Operating Expenses +
1507.15 1518.93 1608.97 1704.3 1704.71
Raw Material
1001.56 1098.52 1058.58 1053.5 1076.13
Increase Decrease in Cost
41.32 -84.44 -56.57 27.35 -12.67
Other Manufacturing Expense
2.66 2.48 3.17 2.43 0
Employee Cost
168.72 180.18 258.16 251.7 256.43
Miscellaneous Expenses
292.89 322.19 345.63 369.32 384.82
Operating Profit
616.06 642.29 674.24 682.58 695.4
Other Income
14.7 28.96 12.04 34.57 38.06
Depreciation
37.88 42.09 53.45 60.61 63.28
Interest
27.96 0.55 1.55 2.41 3.31
Profit before tax and exceptio..
564.92 628.61 631.29 654.13 666.87
Exceptional Items
0 0 0 0 0
PBT
564.92 628.61 631.29 654.13 666.87
Provision for Taxation
146.2 161.65 160.4 168.5 171.2
Net Profit
418.72 466.96 470.89 485.63 495.69
NET Profit after MI
0 0 0 0 0
EPS
35.63 38.11 38.43 39.63 40.44
Operating Profit Margin (%)
29.02 29.72 29.53 28.6 28.97
Net Profit Margin (%)
19.72 21.61 20.62 20.35 20.65

Alivus Life Sciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 74.90 74.90 75.00 75.00 75.00 82.80
FII 6.80 6.40 6.60 6.70 7.80 4.80
Public 5.50 5.60 5.20 4.90 4.20 1.60
Others 12.80 13.10 13.20 13.40 13.00 10.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: